Julie Goodwin, MD has been named section chief of pediatric nephrology effective November 16, 2021. Dr. Goodwin is associate professor of pediatric nephrology, fellowship program director, and has served as the interim section chief of pediatric nephrology since 2019. Dr. Goodwin is chosen after completing an extensive national search for the next leader of the program.
Dr. Goodwin received her medical degree from Boston University School of Medicine and completed both a pediatrics internship and residency at Georgetown University Hospital. She attended Yale School of medicine for her fellowship in pediatric nephrology, and now serves as director of said fellowship program.
Dr. Goodwin began her tenure at Yale Pediatrics in 2007 as an associate research scientist. In 2010, she became assistant professor in the Department of Pediatrics and in 2017, was promoted to associate professor. Dr. Goodwin's NIH-funded research program focuses on determining the role of the glucocorticoid receptor in the endothelium, and more recently, in podocytes, the specialized cells which maintain the filtration barrier in the kidney. She has studied and published extensively on this topic, with research interests spanning fibrosis, glucocorticoids, hypertension, inflammation, nephrology, nephrotic syndrome, steroids, sepsis, and atherosclerosis.
Dr. Goodwin's professional service includes serving as the pediatric nephrology representative on the Make-A-Wish Foundation Medical Advisory Council, editor for Scientific Reports, and scientific review board member for the Charles Hood Foundation. She has been a mentor to many and holds distinguished professional and academic honors including serving as guest professor at Shengjing Hospital of China Medical University, receiving the American Society of Hypertension Eastern Regional Chapter Young Investigator’s Award in Basic Science Research, and placing twice in Yale's Annual Pediatric Fellows Research Day Competition.
In her role as section chief, Dr. Goodwin will continue to oversee the section’s resources and develop and manage the section's clinical, research, and educational programs. She will focus on strategic recruitment, retention, and quality improvement, and represent the section of nephrology in Yale Pediatrics’ policy-making initiatives, appointments and promotions process, and other committees and programs. Dr. Goodwin plans to expand the clinical footprint of the section with the development of new clinical programs while strengthening the research effort.
Yale Pediatrics thanks Dr. Goodwin for her outstanding leadership as acting and interim section chief of pediatric nephrology for the past several years.